Key result
Coadministration of the poliovirus antiviral V-073 with inactivated polio vaccine in mice had no detrimental impact on the elicitation of serum-neutralizing antibodies.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Supports exploration of V-073 with IPV; hypothesis-generating and should not yet change clinical practice.
Immunization of mice with inactivated polio vaccine (IPV) with concurrent dosing of poliovirus antiviral V-073 showed no detrimental impact on the elicitation of serum-neutralizing antibodies. A strategy involving coadministration of antiviral V-073 and IPV can be considered for the management of poliovirus incidents.
No takes yet. Share an insight, caveat, or question.
Kouiavskaia et al. (2011) studied this question. Coadministration of the poliovirus antiviral V-073 with inactivated polio vaccine in mice had no detrimental impact on the elicitation of serum-neutralizing antibodies.
Synapse has enriched 10 related papers. Consider them for comparative context: